BioSpace News Archive

Formerly of Wellstar and Sutter Health, Owen Plietz brings decades of health system experience to Kaiser Permanente

SmileDirectClub, Inc., the oral care company with the first medtech platform for teeth straightening, announced that management will attend the Morgan Stanley 18th Annual Global Healthcare Conference on Thursday, September 17th, with a Fireside Chat that same day at 1:15 PM ET.

Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of the most important unmet patient needs, today announced that Barry Quart, Pharm.D., President and Chief Executive Officer of Heron Therapeutics

Timber Pharmaceuticals, Inc. (“Timber” or the “Company”) (NYSE American: TMBR), a biopharmaceutical company focused on the development and commercialization of treatments for orphan dermatologic diseases, today announced that it will be presenting at the H.C. Wainwright 22nd Annual Global Investment Conference being held virtually from September 14-16, 2020.

Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced that Noridian, the Medicare Administrative Contractor (MAC) for Northern California, has finalized a final local coverage article (LCA) to provide Medicare benefits for serial use of the Signatera molecular residual disease (MRD) test in patients with a history of colorectal cancer.

BioLife Plasma Services, part of the global biopharmaceutical company Takeda Pharmaceutical Company Limited, announced the opening of a new plasma collection center in Warren to collect standard plasma from healthy donors.

Free online resource provides best practices businesses and schools can implement to improve indoor air quality

M-LIFE™ has predicted the toxicity profiles across multiple organ systems for a variety of prospective re-purposed COVID-19 drugs.

Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS) a company dedicated to developing and delivering medicines that make a meaningful difference to people affected by neurological diseases, announced today two presentations on GOCOVRI® (amantadine) extended release capsules (ADS-5102) for the treatment of dyskinesia in patients with Parkinson’s disease receiving levodopa-based therapy at the Movement Disorder Society (MDS) 2020 Virtual Congress,

ARUP Laboratories announced that it now offers testing to detect the virus that causes COVID-19 using saliva specimens.